Steven Cohen Eye Point Pharmaceuticals, Inc. Transaction History

Point72 Asset Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$5.71 - $24.13 $47,393 - $200,279	8,300 New	8,300 $191,000
Q3 2022 Nov 14, 2022	SELL	$6.96 - $11.12 $5.08 Million - $8.11 Million	-729,499 Reduced 59.81%	490,200 $3.88 Million
Q2 2022 Aug 15, 2022	BUY	$7.25 - $12.71 $1.36 Million - $2.38 Million	186,899 Added 18.1%	1,219,699 $9.6 Million
Q1 2022 May 16, 2022	BUY	$8.67 - $14.11 $8.95 Million - $14.6 Million	1,032,800 New	1,032,800 $12.5 Million

176

53.9M

764K

1.57M

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $296M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.